Data / Drug companies / Amantadine hydrochloride
Amantadine hydrochloride: 32 companies and 44 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Amantadine hydrochloride is listed in the FDA National Drug Code Directory by 32 companies, with 44 products in commercial distribution. 44 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; solution; tablet, and the newest product started marketing on June 17, 2026.
The request: Get every company that lists amantadine hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 32
- Products
- 44
- Generic (ANDA) products
- 44 (100.0%)
- Application numbers
- 18
- Routes
- Oral
- Brand names
- Amantadine HCl
- openFDA record search
- api.fda.gov
Companies that list amantadine hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 6 | capsule | Generic drugs (ANDA) | May 21, 2020 |
| Chartwell RX, LLC | 3 | solution; capsule | Generic drugs (ANDA) | June 12, 2017 |
| Coupler LLC | 2 | capsule; tablet | Generic drugs (ANDA) | February 7, 2025 |
| Marlex Pharmaceuticals, Inc. | 2 | capsule, gelatin coated; tablet | Generic drugs (ANDA) | March 1, 2020 |
| Proficient Rx LP | 2 | capsule | Generic drugs (ANDA) | August 4, 2016 |
| Strides Pharma Inc. | 2 | capsule; tablet | Generic drugs (ANDA) | August 4, 2017 |
| Upsher-Smith Laboratories, LLC | 2 | tablet; capsule, gelatin coated | Generic drugs (ANDA) | December 15, 2011 |
| A-S Medication Solutions | 1 | capsule | Generic drugs (ANDA) | February 18, 1987 |
| Advagen Pharma Ltd | 1 | capsule | Generic drugs (ANDA) | May 21, 2020 |
| American Health Packaging | 1 | solution | Generic drugs (ANDA) | February 26, 2024 |
| Atlantic Biologicals Corp. | 1 | solution | Generic drugs (ANDA) | July 17, 1995 |
| AvKARE | 1 | capsule | Generic drugs (ANDA) | June 17, 2026 |
| AvKARE | 1 | capsule, liquid filled | Generic drugs (ANDA) | August 7, 2013 |
| AvPAK | 1 | capsule, liquid filled | Generic drugs (ANDA) | March 28, 2014 |
| Bajaj Medical, LLC | 1 | solution | Generic drugs (ANDA) | July 31, 2025 |
| Bionpharma Inc. | 1 | capsule, liquid filled | Generic drugs (ANDA) | August 15, 2016 |
| Bryant Ranch Prepack | 1 | capsule | Generic drugs (ANDA) | June 12, 2017 |
| Cardinal Health 107, LLC | 1 | solution | Generic drugs (ANDA) | July 17, 1995 |
| Chartwell Governmental & Specialty RX, LLC. | 1 | solution | Generic drugs (ANDA) | June 28, 1993 |
| Epic Pharma, LLC | 1 | capsule | Generic drugs (ANDA) | June 17, 2021 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 1 | capsule | Generic drugs (ANDA) | June 12, 2017 |
| Major Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | June 12, 2017 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | capsule | Generic drugs (ANDA) | January 1, 2017 |
| Pai Holdings, LLC DBA Pai Pharma | 1 | solution | Generic drugs (ANDA) | July 17, 1995 |
| Patrin Pharma, Inc. | 1 | solution | Generic drugs (ANDA) | August 11, 2023 |
| Proficient Rx LP | 1 | capsule | Generic drugs (ANDA) | May 21, 2020 |
| Rising Pharma Holdings, Inc. | 1 | capsule | Generic drugs (ANDA) | September 5, 2022 |
| St. Mary's Medical Park Pharmacy | 1 | capsule | Generic drugs (ANDA) | May 21, 2020 |
| Strides Pharma Science Limited | 1 | capsule, liquid filled | Generic drugs (ANDA) | December 1, 2022 |
| Zhejiang Jutai Pharamceutical Co., Ltd | 1 | tablet | Generic drugs (ANDA) | September 26, 2024 |
| Zydus Lifesciences Limited | 1 | capsule | Generic drugs (ANDA) | August 4, 2016 |
| Zydus Pharmaceuticals USA Inc. | 1 | capsule | Generic drugs (ANDA) | August 4, 2016 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 24 | 54.5% |
| Solution | 9 | 20.5% |
| Tablet | 5 | 11.4% |
| Capsule, liquid filled | 4 | 9.1% |
| Capsule, gelatin coated | 2 | 4.5% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 44 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Influenza A M2 Protein Inhibitor | 44 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.